Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. InnoCan Pharma Corporation
  6. News
  7. Summary
    INNO   CA45783P1027

INNOCAN PHARMA CORPORATION

(INNO)
Delayed CANADIAN NATIONAL STOCK EXCHANGE  -  09:30:00 2023-02-07 am EST
0.3000 CAD    0.00%
2022InnoCan Pharma Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
2022Innocan Pharma Corporation Announces the Addition of Givi Topchishvili, to Advisory Committee, as A Business Strategy Adviser
CI
2022Innovative Delivery Systems Create Unique Opportunities In The Billion-dollar Pain Market (cse : Inno)
AQ
SummaryQuotesChartsNewsCalendarCompanyFinancialsFunds 
 SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about INNOCAN PHARMA CORPORATION
2022InnoCan Pharma Corporation Reports Earnings Results for the Third Quarter and Nine Mont..
CI
2022Innocan Pharma Corporation Announces the Addition of Givi Topchishvili, to Advisory Com..
CI
2022Innovative Delivery Systems Create U : Inno)
AQ
2022Innocan Pharma's Patent Application for Treatment of Psoriasis of the Scalp Reached Nat..
CI
2022Innocan Pharma Reports Another Successful Result from a Pre-Clinical Study on a Dog Suf..
AQ
2022Innocan Pharma Corporation Announces Additional Positive Results in New Preclinical Tri..
CI
2022Innocan Pharma to Participate in the H.C. Wainwright 24th Annual Global Investment Conf..
AQ
2022Innocan Pharma Announces Q2 2022 Results with 70% Annual Increase in Cash Balance and 7..
AQ
2022Innocan Pharma : Md&a q2-2022
PU
2022Innocan Pharma : Financial Statements Q2-2022
PU
2022InnoCan Pharma Corporation Reports Earnings Results for the Second Quarter and Six Mont..
CI
2022Innocan Pharma Meets Pre-Clinical End-Point in Pilot Pain Study on Dogs Using LPT Lipos..
AQ
2022InnoCan Pharma Corporation Meets Pre-Clinical End-Point in Pilot Pain Study on Dogs Usi..
CI
2022Innocan Pharma Is Reaching Close to 100% CBD Bioavailability In a Dog Clinical Study Fo..
AQ
2022InnoCan Pharma Corporation Appoints Roni Kamhi as Chief Operating Officer
CI
More most relevant news
All news about INNOCAN PHARMA CORPORATION
2022InnoCan Pharma Corporation Reports Earnings Results for the Third Quarter and Nine Mont..
CI
2022Innocan Pharma Corporation Announces the Addition of Givi Topchishvili, to Advisory Com..
CI
2022Innovative Delivery Systems Create U : Inno)
AQ
2022Innocan Pharma's Patent Application for Treatment of Psoriasis of the Scalp Reached Nat..
CI
2022Innocan Pharma Reports Another Successful Result from a Pre-Clinical Study on a Dog Suf..
AQ
2022Innocan Pharma Corporation Announces Additional Positive Results in New Preclinical Tri..
CI
2022Innocan Pharma to Participate in the H.C. Wainwright 24th Annual Global Investment Conf..
AQ
2022Innocan Pharma Announces Q2 2022 Results with 70% Annual Increase in Cash Balance and 7..
AQ
2022Innocan Pharma : Md&a q2-2022
PU
2022Innocan Pharma : Financial Statements Q2-2022
PU
More news
News in other languages on INNOCAN PHARMA CORPORATION
2022Innocan Pharma Corporation : Innocan Pharma unterzeichnet einen ersten Beratungsvertrag zu..
2022Innocan Pharma Corporation : Innocan Pharma meldet Ergebnisse für das 3. Quartal 2022 mit ..
2022InnoCan Pharma Corporation annonce ses résultats pour le troisième trimestre et les neu..
2022Innocan Pharma Corporation annonce l'ajout de Givi Topchishvili, au comité consultatif,..
2022Innocan Pharma Corporation : Givi Topchishvili in Advisory Committee von Innocan Pharma au..
2022Innocan Pharma Corporation : Innocan Pharma nimmt Priority ERP-System in Betrieb
2022Innocan Pharma Corporation : Innocan Pharma nimmt an IR Labs Webinar für Anleger am 2. Nov..
2022Innocan Pharma Corporation : Innocan Pharma nimmt am 20. und 21. Oktober an Luxury Meets C..
2022Innocan Pharma Corporation : Innocan Pharmas Patentanmeldung zur Behandlung von Psoriasis ..
2022La demande de brevet d'Innocan Pharma pour le traitement du psoriasis du cuir chevelu a..
More news
Press releases
2022Innovative Delivery Systems Create U : Inno)
AQ
2022Innocan Pharma Reports Another Successful Result from a Pre-Clinical Study on a Dog Suf..
AQ
2022Innocan Pharma to Participate in the H.C. Wainwright 24th Annual Global Investment Conf..
AQ
2022Innocan Pharma Announces Q2 2022 Results with 70% Annual Increase in Cash Balance and 7..
AQ
2022Innocan Pharma : Md&a q2-2022
PU
More press releases
Upcoming event on INNOCAN PHARMA CORPORATION